Pharmafile - Research and Development News
Eliquis did not prove superiority compared to Lovenox
Vismodegib targets most common form of skin cancer
US biotech had filed suit against Lilly earlier this year
First of four pivotal trials fails to meet primary endpoint
Firm will now keep around 650 positions at Sandwich site
Aslan will develop drug initially for gastric and lung cancers